JPY 1327.0
(1.3%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.96 Billion JPY | 16.93% |
2022 | 1.62 Billion JPY | 9.43% |
2021 | 1.49 Billion JPY | 14.61% |
2020 | 1.29 Billion JPY | 42.37% |
2019 | 917.88 Million JPY | 15.87% |
2018 | 804.98 Million JPY | 9.35% |
2017 | 742.52 Million JPY | 27.62% |
2016 | 549.75 Million JPY | 24.77% |
2015 | 462.71 Million JPY | 9.03% |
2014 | 428.1 Million JPY | 26.92% |
2013 | 332.25 Million JPY | -7.57% |
2012 | 363.99 Million JPY | 32.88% |
2011 | 290.84 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 381 Million JPY | -37.49% |
2023 FY | - JPY | 16.93% |
2023 Q3 | 464.52 Million JPY | 20.13% |
2023 Q1 | 397.47 Million JPY | -23.35% |
2023 Q2 | 386.69 Million JPY | -2.71% |
2023 Q4 | 611.18 Million JPY | 31.57% |
2022 Q4 | 518.58 Million JPY | 56.88% |
2022 FY | - JPY | 9.43% |
2022 Q3 | 330.55 Million JPY | 28.09% |
2022 Q2 | 258.06 Million JPY | -0.73% |
2022 Q1 | 259.96 Million JPY | -39.96% |
2021 FY | - JPY | 14.61% |
2021 Q2 | 261.67 Million JPY | -8.04% |
2021 Q4 | 432.97 Million JPY | 113.99% |
2021 Q1 | 284.54 Million JPY | -22.33% |
2021 Q3 | 202.33 Million JPY | -22.68% |
2020 Q1 | 177.46 Million JPY | -44.1% |
2020 Q2 | 186.05 Million JPY | 4.84% |
2020 FY | - JPY | 42.37% |
2020 Q3 | 358.34 Million JPY | 92.6% |
2020 Q4 | 366.36 Million JPY | 2.24% |
2019 Q1 | 159.07 Million JPY | -53.07% |
2019 FY | - JPY | 15.87% |
2019 Q2 | 156.8 Million JPY | -1.42% |
2019 Q4 | 317.46 Million JPY | 197.18% |
2019 Q3 | 106.82 Million JPY | -31.87% |
2018 Q4 | 338.94 Million JPY | 280.12% |
2018 Q2 | 96.92 Million JPY | -18.2% |
2018 Q1 | 118.48 Million JPY | -57.98% |
2018 FY | - JPY | 9.35% |
2018 Q3 | 89.16 Million JPY | -8.01% |
2017 Q3 | 138.78 Million JPY | 43.59% |
2017 FY | - JPY | 27.62% |
2017 Q1 | 137.35 Million JPY | -29.9% |
2017 Q4 | 281.95 Million JPY | 103.15% |
2017 Q2 | 96.65 Million JPY | -29.63% |
2016 Q4 | 195.94 Million JPY | 123.21% |
2016 FY | - JPY | 24.77% |
2016 Q3 | 87.78 Million JPY | -46.93% |
2016 Q2 | 165.41 Million JPY | 90.71% |
2016 Q1 | 86.73 Million JPY | -59.55% |
2015 Q2 | 106.23 Million JPY | 58.38% |
2015 Q4 | 214.44 Million JPY | 548.73% |
2015 Q3 | 33.05 Million JPY | -68.88% |
2015 FY | - JPY | 9.03% |
2015 Q1 | 67.07 Million JPY | -44.23% |
2014 FY | - JPY | 26.92% |
2014 Q4 | 120.27 Million JPY | 35.93% |
2014 Q3 | 88.48 Million JPY | -33.22% |
2014 Q2 | 132.5 Million JPY | 155.56% |
2014 Q1 | 51.84 Million JPY | -71.68% |
2013 Q1 | 18.22 Million JPY | -84.83% |
2013 Q3 | 67.9 Million JPY | 131.09% |
2013 Q4 | 183.06 Million JPY | 169.57% |
2013 FY | - JPY | -7.57% |
2013 Q2 | 29.38 Million JPY | 61.28% |
2012 FY | - JPY | 32.88% |
2012 Q2 | -1 Million JPY | 0.0% |
2012 Q3 | 18 Million JPY | 1900.0% |
2012 Q4 | 120.09 Million JPY | 567.17% |
2011 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -23.737% |
Euglena Co., Ltd. | 676 Million JPY | -190.655% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -253.541% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 51.038% |
Kao Corporation | 154.49 Billion JPY | 98.728% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -43.468% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 95.978% |
Shiseido Company, Limited | 106.46 Billion JPY | 98.154% |
Lion Corporation | 42.31 Billion JPY | 95.357% |
Mandom Corporation | 6.69 Billion JPY | 70.67% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -709.905% |
Milbon Co., Ltd. | 7.8 Billion JPY | 74.811% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -52.481% |
Fancl Corporation | 16.6 Billion JPY | 88.166% |
KOSÉ Corporation | 26.85 Billion JPY | 92.684% |
Cota Co., Ltd. | 2.26 Billion JPY | 13.385% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 249.495% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -1043.36% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 91.523% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 83.953% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -1484.54% |
Almado, Inc. | 983.21 Million JPY | -99.837% |
I-ne CO., LTD. | 4.7 Billion JPY | 58.195% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 413.37% |
Liberta Co.,Ltd. | 318.19 Million JPY | -517.498% |
AXXZIA Inc. | 1.28 Billion JPY | -52.726% |
S.T. Corporation | 2.62 Billion JPY | 25.178% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 93.799% |
Earth Corporation | 10.6 Billion JPY | 81.478% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -79.511% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 442.316% |
Ya-Man Ltd. | 1.43 Billion JPY | -36.753% |
MTG Co., Ltd. | 4.39 Billion JPY | 55.284% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 66.178% |
SHOBIDO Corporation | 1.11 Billion JPY | -76.98% |
Artnature Inc. | 3.78 Billion JPY | 48.116% |
Pigeon Corporation | 15.8 Billion JPY | 87.569% |
Unicharm Corporation | 178.01 Billion JPY | 98.896% |
Paltac Corporation | 35.92 Billion JPY | 94.53% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 40.188% |